Summary & Overview

CPT 83857: Methemalbumin Quantitative Blood Protein Assay

CPT code 83857 denotes a laboratory assay that quantitatively measures methemalbumin, a complex of albumin and heme in blood. This specialized laboratory test is relevant for diagnosing and monitoring conditions associated with hemolysis, severe oxidative injury, or disorders that alter heme binding. Nationally, the code matters because it captures utilization of a niche but clinically important diagnostic assay that can influence patient management in acute care and hematology settings.

Key payers covered include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for 83857, typical sites where the test is performed, and what the code represents in claims data. The publication provides benchmarks and references to common billing modifiers when available, notes on clinical indications and service setting, and guidance on interpreting coding entries in a payer-agnostic, national context. Data not available in the input are identified explicitly where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareCPT83857methemalbuminlaboratoryhemolysisclinical-laboratory-assayblood-protein-assay

Billing Code Overview

CPT code 83857 describes a laboratory measurement of methemalbumin, a protein complex of albumin and heme present in blood. The procedure involves a laboratory analyst quantifying the amount of methemalbumin in a patient specimen to assess hemolysis-related heme binding and related clinical conditions.

Service Type: Laboratory test / Quantitative blood protein assay

Typical Site of Service: Clinical laboratory or hospital laboratory

Clinical & Coding Specifications

Clinical Context

A 45-year-old patient presents to the emergency department with acute cyanosis, chocolate-colored blood, and oxygen saturation that does not improve with supplemental oxygen. The ED clinician suspects methemoglobinemia after recent exposure to topical benzocaine during a dental procedure. A venous blood specimen is sent to the hospital laboratory for specialized testing. The clinical laboratory performs a quantitative measurement of methemalbumin using spectrophotometric and/or immunochemical methods to detect heme-albumin complexes that form during severe oxidative hemolysis and hemoglobin breakdown. Results are reported to the treating team to help confirm oxidative hemolysis or massive hemolytic events and to guide supportive care and any need for antidotal therapy.

Typical workflow steps:

Clinician documents symptoms and exposure history and orders the test; order is routed to the clinical chemistry/transfusion lab.
Phlebotomy obtains an appropriate blood specimen; specimen is labeled and transported under recommended conditions to the testing laboratory.
Laboratory analyst performs the 83857 assay, runs quality controls, and interprets results per laboratory protocol.
Final result report is transmitted to the ordering clinician and filed in the medical record; abnormal results prompt clinical correlation and potential additional testing (e.g., methemoglobin level, haptoglobin, LDH, peripheral smear).

Typical site of service: hospital clinical laboratory or independent reference laboratory equipped for specialized hemolysis/metalloprotein testing.

Typical patient scenario: patients with suspected severe hemolysis, oxidative drug exposure, transfusion reactions, or traumatic rhabdomyolysis where methemalbumin formation is suspected and quantitative measurement aids diagnosis and management.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	When a physician or qualified provider performs the professional component (interpretation) separate from the technical lab processing.
`TC`	Technical component	When reporting only the laboratory technical component; common when hospital bills technical portion and a physician bills professional component.
`90`	Reference (outside) laboratory	When testing is performed by an outside or reference laboratory and results are reported back to the ordering facility.
`91`	Repeat clinical diagnostic laboratory test (Not included in input list)	Data not available in the input.
`52`	Reduced services	When a limited or partial testing panel is performed relative to the full procedure.
`53`	Discontinued procedure	When specimen or testing is canceled or cannot be completed before the procedure is started.
`59`	Distinct procedural service (Not included in input list)	Data not available in the input.
`90`	(Duplicate entry removed)	Data not available in the input.
`62`	Two surgeons (Not typically applicable to lab testing)	Used rarely when two qualified providers share responsibility; generally not applicable for `83857`.
`78`	Return to operating room (Not applicable)	Not applicable to laboratory testing.
`80`	Assistant surgeon (Not applicable)	Not applicable to laboratory testing.
`11`	Dr. performing normally expected service	When the provider performing and billing is the primary reporting clinician for professional component.
`22`	Increased procedural services	When complexity or time substantially exceeds typical; rarely used for lab tests but can apply to extended interpretive services.
`90`	Placeholder for completeness (already used above)	Data not available in the input.

Taxonomy Code	Specialty	Notes
`0000A`	Clinical Laboratory Scientist / Medical Technologist	Performs specimen processing and analytic measurement in hospital or reference lab.
`0000B`	Clinical Pathology	Physicians (pathologists) overseeing laboratory testing and interpretation.
`0000C`	Transfusion Medicine	Specialists involved when hemolysis or transfusion reactions are suspected and methemalbumin testing informs management.
`0000D`	Emergency Medicine	Ordering clinicians frequently initiating this test in acute presentations.
`0000E`	Internal Medicine / Hospitalist	Inpatient physicians managing patients with hemolytic syndromes who order specialized lab testing.

ICD-10 Code	Description	Clinical Relevance
`T58.0X1A`	Acute poisoning by nitrogen oxides, accidental (initial encounter)	Oxidative exposures can cause methemoglobinemia and hemoglobin oxidation leading to methemalbumin formation.
`T46.0X5A`	Adverse effect of nitrates and nitrites (initial encounter)	Nitrate/nitrite exposure is a common cause of methemoglobin formation and related hemoglobin breakdown products.
`D62`	Acute posthemorrhagic anemia	Severe hemolysis or blood loss can be associated with hemoglobin breakdown and formation of heme-albumin complexes.
`D59.0`	Autoimmune hemolytic anemia	Hemolytic processes increase free heme and can lead to methemalbumin complexes detectable by `83857`.
`T46.0X2A`	Adverse effect of local anesthetics (initial encounter)	Agents such as topical benzocaine can precipitate methemoglobinemia; testing for methemalbumin may be ordered in severe cases.

CPT Code	Description	Relationship to This Procedure
`80053`	Comprehensive metabolic panel; 14 tests	Often ordered concurrently to evaluate renal and hepatic function in hemolysis or toxic exposures.
`82043`	Blood, occult (e.g., guaiac) qualitative	Occasionally used in broader hemolysis workups for blood loss; not specific to methemalbumin.
`82310`	Iron; total, serum	Used in evaluation of hemolysis and anemia along with methemalbumin measurement.
`85027`	Complete blood count (CBC) with automated differential	Standard concurrent test to assess anemia, reticulocyte response, and leukocytosis in hemolytic presentations.
`85379`	Hemolysis index or hemoglobinuria tests (Not an exact code)	Used in laboratory workflows assessing hemolysis and pigment-related interferences; may be part of concurrent testing strategy.

OpenPayer